Shanghai Theorion Pharmaceutical Co Ltd.
1 clinical trials · Sponsor
◉ Watch Shanghai Theorion Pharmaceutical Co Ltd.
| Record | Firm | Date |
|---|---|---|
| Safety, Pharmacokinetics and Efficacy Study of Bisthianostat in Refractory or Recurrent Multiple Myeloma Patients (NCT03618602) | Shanghai Theorion Pharmaceutical Co Ltd. | 2018-04-25 |
Track Shanghai Theorion Pharmaceutical Co Ltd. automatically
Every clearance here is in the API, with alerts when new ones post.